GROHMANN, Ursula
 Distribuzione geografica
Continente #
NA - Nord America 8.341
EU - Europa 5.630
AS - Asia 5.122
SA - Sud America 922
Continente sconosciuto - Info sul continente non disponibili 577
AF - Africa 133
OC - Oceania 7
Totale 20.732
Nazione #
US - Stati Uniti d'America 8.103
SG - Singapore 2.454
IT - Italia 1.210
IE - Irlanda 793
CN - Cina 762
BR - Brasile 700
UA - Ucraina 674
HK - Hong Kong 611
RU - Federazione Russa 556
VN - Vietnam 552
SE - Svezia 515
DE - Germania 424
FR - Francia 368
RO - Romania 279
FI - Finlandia 252
GB - Regno Unito 182
IN - India 142
CA - Canada 120
KR - Corea 109
BD - Bangladesh 77
AR - Argentina 71
TR - Turchia 66
CZ - Repubblica Ceca 57
MX - Messico 53
BE - Belgio 49
CO - Colombia 48
IQ - Iraq 47
AT - Austria 44
PL - Polonia 44
NL - Olanda 43
JP - Giappone 41
PK - Pakistan 39
ZA - Sudafrica 37
ID - Indonesia 36
CH - Svizzera 34
EC - Ecuador 34
ES - Italia 29
UZ - Uzbekistan 28
VE - Venezuela 25
GR - Grecia 22
PH - Filippine 20
CI - Costa d'Avorio 19
JM - Giamaica 18
SA - Arabia Saudita 17
LB - Libano 15
MA - Marocco 14
CL - Cile 11
CR - Costa Rica 11
MY - Malesia 11
JO - Giordania 10
LT - Lituania 10
PE - Perù 10
PY - Paraguay 10
AZ - Azerbaigian 9
EU - Europa 9
KE - Kenya 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 8
PS - Palestinian Territory 8
TH - Thailandia 8
EG - Egitto 7
IL - Israele 7
NI - Nicaragua 6
NP - Nepal 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
EE - Estonia 5
GE - Georgia 5
OM - Oman 5
PT - Portogallo 5
AU - Australia 4
BG - Bulgaria 4
GT - Guatemala 4
HU - Ungheria 4
IR - Iran 4
KW - Kuwait 4
KZ - Kazakistan 4
MD - Moldavia 4
NG - Nigeria 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
LC - Santa Lucia 3
LV - Lettonia 3
MN - Mongolia 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BZ - Belize 2
GA - Gabon 2
KG - Kirghizistan 2
LR - Liberia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
Totale 20.122
Città #
Singapore 1.841
Chandler 861
Dublin 793
San Jose 682
Hong Kong 606
Perugia 599
Ashburn 528
San Mateo 440
Jacksonville 343
Boardman 301
Santa Clara 292
Bucharest 273
Council Bluffs 234
Dong Ket 226
Altamura 204
Beijing 201
Wilmington 197
Medford 192
Moscow 191
Princeton 190
Munich 157
Lauterbourg 156
Lawrence 153
Redmond 139
Ann Arbor 136
Los Angeles 132
Des Moines 130
Andover 121
New York 103
Ho Chi Minh City 102
Seoul 101
Falls Church 92
The Dalles 79
São Paulo 78
Hanoi 69
Dallas 63
Turku 55
Orem 52
Saint Petersburg 51
Dearborn 50
Brussels 49
Chicago 49
Helsinki 47
Woodbridge 44
Norwalk 43
Piscataway 43
Chennai 36
Montreal 36
Houston 35
Phoenix 35
San Paolo di Civitate 35
Tokyo 34
Brno 32
Brooklyn 32
Rome 32
Warsaw 31
Atlanta 30
Frankfurt am Main 28
Nuremberg 28
Johannesburg 26
Pisa 26
Milan 25
Shanghai 25
Izmir 24
Boston 23
Columbus 23
Fremont 23
Redwood City 23
Denver 22
London 22
Toronto 22
Olomouc 21
Rio de Janeiro 21
Abidjan 19
Vienna 19
Baghdad 18
Haiphong 18
Manchester 17
Mumbai 17
Stockholm 17
Bogotá 15
Brasília 15
Da Nang 15
Poplar 15
Tashkent 15
Amsterdam 14
Buffalo 14
Medellín 14
Mexico City 14
Nanjing 14
San Francisco 14
Lahore 13
Seattle 13
Ankara 12
Auburn Hills 12
Bologna 12
Falkenstein 12
Guangzhou 12
Hefei 12
Ottawa 12
Totale 12.632
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 231
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 217
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 212
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 208
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 208
Amino-acid sensing and degrading pathways in immune regulation 203
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 193
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 192
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 188
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 188
Amino acid metabolism as drug target in autoimmune diseases 185
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 178
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 170
Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. 169
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 169
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 167
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 164
Fragment-based approach to identify IDO1 inhibitor building blocks 161
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 156
Is It Time to Use Probiotics to Prevent or Treat Obesity? 155
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 155
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine 155
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 154
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 154
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 152
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 151
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 151
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 148
T cell apoptosis by kynurenines. 146
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 146
Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease 143
The TGF-β/IDO axis in infectious tolerance. 141
Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1 141
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 140
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 139
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 137
A TLR9/TRIF pathway induces tolerance via TGF-beta and tryptophan catabolism in plasmacytoid dendritic cells 135
Increase of natural killer activity of mouse lymphocytes following in vitro and in vivo treatment with lithium. 134
A novel metabotropic glutamate receptor 4 allosteric modulator effective in multiple sclerosis experimental autoimmune encephalomyelitis (EAE) mouse model 134
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 134
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. 133
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 133
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 133
Xenograft of microencapsulated sertoli cells reverses T1DM in NOD mice by inducing neogenesis of beta-cells. 132
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 132
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 132
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 131
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 131
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 131
Dual effect of IL-4 on resistance to systemic gram-negative infection and production on TNF-alfa 130
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 127
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 127
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 127
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 126
Microscale thermophoresis and docking studies suggest lapachol and auraptene are ligands of IDO1 126
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 125
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 123
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 123
Tryptophan catabolism in IDO+ plasmacytoid dendritic cells 121
The immunosuppressive activity of proinflammatory cytokines in experimental models: potential for therapeutic intervention in autoimmunity. 120
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 119
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 119
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 119
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 119
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 117
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. 117
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 116
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 115
Modulation of tryptophan catabolism by regulatory T cells 114
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 113
Interleukin-6 (IL-6) prevents activation-induced cell death (AICD): Interleukin-2-independent inhibition of Fas/FasL expression and cell death 112
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 112
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 112
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma 112
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 109
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease 109
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 108
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 107
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 106
Ligand Binding and Functional Selectivity ofl-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR) 106
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 106
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 106
T cell apoptosis by tryptophan catabolism 105
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 105
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. 105
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 105
Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. 104
A general partnership between AhR and tryptophan catabolic enzymes and its role in endotoxin tolerance 104
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 104
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 104
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 104
CTLA-4-Ig regulates tryptophan catabolism in vivo. 103
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 103
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 102
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 102
Induction of immunosuppressive functions and NF-kappa B by FLIP in monocytes 102
The landscape of AhR regulators and coregulators to fine-tune AhR functions 102
Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens. 101
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 101
Loss of IDO1 Expression From Human Pancreatic -Cells Precedes Their Destruction During the Development of Type 1 Diabetes 101
Totale 13.497
Categoria #
all - tutte 88.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.824 0 0 0 100 100 58 29 521 151 216 199 450
2022/20233.021 207 559 39 228 278 351 3 144 1.047 10 108 47
2023/20241.175 85 147 37 23 8 10 296 31 104 26 166 242
2024/20252.687 37 225 141 151 327 144 113 190 508 157 422 272
2025/20266.410 394 438 378 859 823 618 1.117 396 663 524 137 63
2026/20271.399 130 201 393 675 0 0 0 0 0 0 0 0
Totale 20.732